Focused review: physiatric management of HIV-related disability (Q40969189)

25 September 2017

title

Focused review: physiatric management of HIV-related disability (English)

1 reference

25 September 2017

0 references

M W O'Dell

1

1 reference

25 September 2017

S F Levinson

series ordinal

2

1 reference

25 September 2017

R V Riggs

series ordinal

3

1 reference

25 September 2017

publication date

1 March 1996

1 reference

Archives of Physical Medicine and Rehabilitation

25 September 2017

published in

1 reference

25 September 2017

volume

77

1 reference

25 September 2017

issue

3 Suppl

1 reference

25 September 2017

page(s)

S66-73

1 reference

Prevention of HIV infection. Looking back, looking ahead

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

The molecular biology of human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

Rehabilitation medicine consultation in persons hospitalized with AIDS. An analysis of thirty cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

NIH conference. HIV vaccine development: a progress report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

Neurologic manifestations of HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

Energy expenditure and wasting in human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

Aerobic Exercise Training in an AIDS Risk Group*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

Human immunodeficiency virus infection, exercise and athletics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

Rheumatic manifestations of human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

Management of neurobehavioral impairment in HIV-1 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

The reliability and validity of two HIV-specific health-related Quality-of-Life measures: a preliminary analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

Clinical aspects of HIV infection in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

Cerebral infarctions and transient neurologic deficits associated with acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

HIV disease and the endocrine system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

Therapy for human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

Rheumatologic manifestations of infection with human immunodeficiency virus (HIV).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

Disability in persons hospitalized with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

Human Immunodeficiency Virus-Related Cognitive Impairment and the Acquired Immunodeficiency Syndrome Dementia Complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

Quality of Life in Persons with Human Immunodeficiency Virus Infection: Measurement by the Medical Outcomes Study Instrument

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

Experience with rehabilitation in the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

7 January 2021

Cerebrovascular disease in AIDS: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

7 January 2021

Neurorehabilitation and HIV infection: clinical and ethical dilemmas.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

7 January 2021

Psychological distress and neuropsychological complications of HIV infection and AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2896%2990247-6

7 January 2021

10.1016/S0003-9993(96)90247-6

Identifiers

DOI

1 reference

25 September 2017

1 reference